KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Asset Utilization Ratio (2016 - 2025)

Rigel Pharmaceuticals has reported Asset Utilization Ratio over the past 15 years, most recently at 0.78 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.78 for Q4 2025, down 34.14% from a year ago — trailing twelve months through Dec 2025 was 0.78 (down 34.14% YoY), and the annual figure for FY2025 was 0.87, down 31.88%.
  • Asset Utilization Ratio for Q4 2025 was 0.78 at Rigel Pharmaceuticals, down from 1.26 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for RIGL hit a ceiling of 1.4 in Q2 2025 and a floor of 0.54 in Q1 2022.
  • Median Asset Utilization Ratio over the past 5 years was 1.0 (2023), compared with a mean of 0.96.
  • Biggest five-year swings in Asset Utilization Ratio: crashed 34.55% in 2022 and later soared 87.13% in 2023.
  • Rigel Pharmaceuticals' Asset Utilization Ratio stood at 0.84 in 2021, then rose by 14.09% to 0.96 in 2022, then rose by 4.45% to 1.01 in 2023, then rose by 17.57% to 1.18 in 2024, then plummeted by 34.14% to 0.78 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.78 (Q4 2025), 1.26 (Q3 2025), and 1.4 (Q2 2025) per Business Quant data.